1. Aguiree F, Brown A, Cho NH, Dahlquist G, Dodd S, Dunning T, et al. IDF diabetes atlas. 6th ed. Basel: International Diabetes Federation; 2013.
2. Redmond JM, McKenna MJ, Feingold M, Ahmad BK. Sensory testing versus nerve conduction velocity in diabetic polyneuropathy. Muscle Nerve 1992;15:1334-9.
3. Joo IS. Controversies on the usefulness of nerve conduction study in the early diagnosis of diabetic polyneuropathy. Ann Clin Neurophysiol 2008;10:25-8.
4. American Diabetes Association American Academy of Neurology. Consensus statement: report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes Care 1988;11:592-7.
5. Park JM, Kang SJ, Kim KW, Kim JW, Kim SH. Evaluation of peripheral polyneuropathy in patients with diabetes mellitus using quantitative sensory test. J Korean Acad Rehabil Med 2001;25:102-9.
6. Mueller D, Obermann M, Koeppen S, Kavuk I, Yoon MS, Sack F, et al. Electrically evoked nociceptive potentials for early detection of diabetic small-fiber neuropathy. Eur J Neurol 2010;17:834-41.
7. Bradham DD. Outcomes research in orthopedics: history, perspectives, concepts, and future. Arthroscopy 1994;10:493-501.
8. Herr KA, Mobily PR, Kohout FJ, Wagenaar D. Evaluation of the Faces Pain Scale for use with the elderly. Clin J Pain 1998;14:29-38.
9. Hicks CL, von Baeyer CL, Spafford PA, van Korlaar I, Goodenough B. The Faces Pain Scale-Revised: toward a common metric in pediatric pain measurement. Pain 2001;93:173-83.
11. Hansson P, Backonja M, Bouhassira D. Usefulness and limitations of quantitative sensory testing: clinical and research application in neuropathic pain states. Pain 2007;129:256-9.
13. Chun SW, Ko KS. Summary of the update to the diabetic neuropathy management guidebook. J Korean Diabetes 2012;13:115-23.
14. Jin WJ, Yu TY, Jin YH, Lee JB. Visual analogue scale in acute pain measurement: its usefulness as a pain measurement tool in an emergency setting. J Korean Soc Emerg Med 2003;14:61-5.
15. Bijur PE, Silver W, Gallagher EJ. Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med 2001;8:1153-7.
16. Jensen MP, McFarland CA. Increasing the reliability and validity of pain intensity measurement in chronic pain patients. Pain 1993;55:195-203.
17. Jenkinson C, Wright L, Coulter A. Criterion validity and reliability of the SF-36 in a population sample. Qual Life Res 1994;3:7-12.
19. Lee SM, Kim BJ. Diagnostic usefulness of quantitative sensory test in diabetic polyneuropathy: comparison with nerve conduction study. J Korean Neurol Assoc 1999;17:106-11.
20. Donaghue VM, Giurini JM, Rosenblum BI, Weissman PN, Veves A. Variability in function measurements of three sensory foot nerves in neuropathic diabetic patients. Diabetes Res Clin Pract 1995;29:37-42.
21. Borsey DQ, Cull RE, Fraser DM, Ewing DJ, Campbell IW, Clarke BF. Small muscle wasting of the hands in diabetes mellitus. Diabetes Care 1983;6:10-7.
22. Ziegler D, Mayer P, Wiefels K, Gries FA. Assessment of small and large fiber function in long-term type 1 (insulin-dependent) diabetic patients with and without painful neuropathy. Pain 1988;34:1-10.
23. Jamal GA, Hansen S, Weir AI, Ballantyne JP. The neurophysiologic investigation of small fiber neuropathies. Muscle Nerve 1987;10:537-45.
24. Dyck PJ, Lambert EH, O’Brien PC. Pain in peripheral neuropathy related to rate and kind of fiber degeneration. Neurology 1976;26:466-71.
25. Cazzato D, Lauria G. Small fibre neuropathy. Curr Opin Neurol 2017;30:490-9.
27. Katsarava Z, Ayzenberg I, Sack F, Limmroth V, Diener HC, Kaube H. A novel method of eliciting pain-related potentials by transcutaneous electrical stimulation. Headache 2006;46:1511-7.